DMAA Product OxyElite Pro Named Potential Link In Acute Hepatitis Cases
This article was originally published in The Tan Sheet
Executive Summary
FDA is investigating 29 reports of acute non-viral hepatitis in Hawaii, and the state Department of Health says 24 cases share a common link to the use of products labeled as USPlabs’ DMAA product, OxyElite Pro.
You may also be interested in...
GNC Supply Chain Reform Pays Dividends In DoJ Settlement From DMAA Investigation
DoJ announces a "non-prosecution agreement" that requires GNC to pay $2.25m and to cooperate in dietary supplement market investigations conducted by FDA and other federal agencies, including the current litigation against USPlabs.
Federal Sweep Nets 40 Criminal, Civil Cases For Spiked Supplements, Disease Claims
A deputy assistant attorney general clarifies that ongoing investigations target “unlawful makers and marketers of dietary supplements,” but DoJ and other agencies broadly warn the entire industry about the potential for additional criminal cases as well as civil complaints.
Federal Sweep Nets 40 Criminal, Civil Cases For Spiked Supplements, Disease Claims
A deputy assistant attorney general clarifies that ongoing investigations target “unlawful makers and marketers of dietary supplements,” but DoJ and other agencies broadly warn the entire industry about the potential for additional criminal cases as well as civil complaints.